CNX
67
4
CF
47
5
ALL
37
3
FIS
43
5
TAP
57
6
GWW
50
9
CNP
59
17
INTC
35
4
MU
42
14
NOV
45
2
PFG
27
7
PDCO
77
3
PX
56
3
XOM
33
3
SO
48
6
T
32
2
F
38
4
ORLY
48
3
EXPD
29
2
CMCSA
49
3
CNX
67
4
CF
47
5
ALL
37
3
FIS
43
5
TAP
57
6
GWW
50
9
CNP
59
17
INTC
35
4
MU
42
14
NOV
45
2
PFG
27
7
PDCO
77
3
PX
56
3
XOM
33
3
SO
48
6
T
32
2
F
38
4
ORLY
48
3
EXPD
29
2
CMCSA
49
3
Financhill
Back

Alterity Therapeutics 10K Form

Sell
45

ATHE
Alterity Therapeutics

Last Price:
$2.20
Seasonality Move:
-7.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATHE News And Ratings

See the #1 stock for the next 7 days that we like better than ATHE

ATHE Financial Statistics

Sales & Book Value

Annual Sales: $99.8K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 2.09

Profitability

Net Income (TTM): $0
Gross Margin: $189.6K
Return on Equity: 0%
Return on Assets: 0%

Alterity Therapeutics Earnings Forecast

Key Alterity Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for ATHE is 100.00%.
  • The Selling, General & Administrative Expenses for ATHE have been equal to 2,981.41% of Gross Profit Margin.
  • The Interest Expense is -0.22% of Operating Income.
  • Per Share Earnings over the last 27 years have been positive in 12 years.

Alterity Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATHE
CUSIP: 02155X
Website: alteritytherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATHE Technical Analysis vs Fundamental Analysis

Sell
45
Alterity Therapeutics (ATHE) is a Sell

Is Alterity Therapeutics a Buy or a Sell?